TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Hofseth BioCare ASA
Closing information (x1000 EUR)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
16,976
|
11,317
|
7,708 |
| Financial expenses |
1,183
|
1,248
|
1,161 |
| Earnings before taxes |
-9,491
|
-13,052
|
-12,680 |
| Total assets |
34,706
|
39,048
|
41,708 |
| Current assets |
11,654
|
16,696
|
17,076 |
| Current liabilities |
22,408
|
16,362
|
15,133 |
| Equity capital |
3,660
|
14,063
|
14,075 |
| - share capital |
351
|
375
|
359 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
10.5%
|
36.0%
|
33.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-55.9%
|
-115.3%
|
-164.5% |
| Return on assets (ROA) |
-23.9%
|
-30.2%
|
-27.6% |
| Current ratio |
52.0%
|
102.0%
|
112.8% |
| Return on equity (ROE) |
-259.3%
|
-92.8%
|
-90.1% |
| Change turnover |
6,378
|
4,014
|
2,443 |
| Change turnover % |
60%
|
55%
|
46% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.